SCHEMBL470575

SCHEMBL470575

CC(C)(C)OC(=O)N[C@H]1CNC[C@@H]1c1cc(CF)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C19 P33261 3/20 0.38
KCNH2 Q12809 3/20 0.38
KDM1A O60341 2/20 0.37
CYP2C9 P11712 2/20 0.36
MAOB P27338 2/20 0.36
MAOA P21397 1/20 0.36
EPHX2 P34913 1/20 0.35
PARP1 P09874 3/20 0.34
AKT1 P31749 2/20 0.34
FPR1 P21462 2/20 0.33
FPR2 P25090 1/20 0.33
GAA P10253 1/20 0.33
AAK1 Q2M2I8 2/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146482 0.87 KDM1A (0.40) KDM1AMAOBMAOAEPHX2FPR1
SCHEMBL146483 0.87 KDM1A (0.40) KDM1AMAOBMAOAEPHX2FPR1
SCHEMBL146484 0.87 KDM1A (0.40) KDM1AMAOBMAOAEPHX2FPR1
SCHEMBL458267 0.86 KDM1A (0.39) CYP3A4CYP2D6CYP2C19KCNH2KDM1A
SCHEMBL462830 0.83 KDM1A (0.39) CYP3A4CYP2D6CYP2C19KCNH2KDM1A
SCHEMBL148173 0.83 KDM1A (0.39) CYP3A4CYP2D6CYP2C19KCNH2KDM1A
SCHEMBL170772 0.83 KDM1A (0.39) CYP3A4CYP2D6CYP2C19KCNH2KDM1A
SCHEMBL14722720 0.82 EPHX2 (0.44) CYP3A4CYP2D6CYP2C19KCNH2KDM1A
SCHEMBL458054 0.82 EPHX2 (0.44) CYP3A4CYP2D6CYP2C19KCNH2KDM1A
SCHEMBL462835 0.81 FPR1 (0.46) KDM1AEPHX2AKT1FPR1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed